UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 398

Sortiert nach

Choice of initial regimen for antiretroviral-naïve HIV patients: Analysis of motivation

La revue de medecine interne, 2016-12, Vol.37 (12), p.796-801

2016

Volltextzugriff (PDF)

Les urgences andrologiques en milieu urbain au Cameroun: aspects cliniques et thérapeutiques

Andrologie (Lille, France), 2012-12, Vol.22 (4), p.223-226

2012

Volltextzugriff (PDF)

Social integration of women operated for obstetric urogenital fistula

Progrès en urologie (Paris), 2013-10, Vol.23 (12), p.1000-1003

2013

Volltextzugriff (PDF)

Prise en charge du priapisme à Dakar

Andrologie (Lille, France), 2012-03, Vol.22 (1), p.36-41

2012

Volltextzugriff (PDF)

Problématique de la prise en charge des anomalies de la différenciation sexuelle dans le service d’urologie : CHU Point G

Progrès en urologie (Paris), 2013-01, Vol.23 (1), p.66-72

2013

Volltextzugriff (PDF)

Vulval bilharziasis

Progrès en urologie (Paris), 2008-05, Vol.18 (5), p.327-329

2008

Volltextzugriff (PDF)

Localisation vulvaire de la bilharziose

Progrès en urologie (Paris), 2008-05, Vol.18 (5), p.327-329

2008

Volltextzugriff (PDF)

Issues inherent to the management of disorders of sex development in Point G Hospital

Progrès en urologie (Paris), 2013-01, Vol.23 (1), p.66-72

2013

Volltextzugriff (PDF)

Sexuality and fertility of women operated for obstetric urogenital fistulae

Progrès en urologie (Paris), 2014-11, Vol.24 (13), p.876-876

2014

Volltextzugriff (PDF)

Analyse des motivations du choix des antirétroviraux (ARV) prescrits chez des patients infectés par le VIH (PVVIH) naïfs

La revue de medecine interne, 2016-12, Vol.37 (12), p.796-801

2016

Volltextzugriff (PDF)

Gag Mutations Can Impact Virological Response to Dual-Boosted Protease Inhibitor Combinations in Antiretroviral-Naïve HIV-Infected Patients

Antimicrobial Agents and Chemotherapy, 2010-07, Vol.54 (7), p.2910-2919

2010

Volltextzugriff (PDF)

Intégration sociale des femmes opérées de fistule urogénitale obstétricale

Progrès en urologie (Paris), 2013-10, Vol.23 (12), p.1000-1003

2013

Volltextzugriff (PDF)

Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial

Journal of antimicrobial chemotherapy, 2013-03, Vol.68 (3), p.690-696

2013

Volltextzugriff (PDF)

Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients

AIDS (London), 2013-01, Vol.27 (1), p.69-80

2013

Volltextzugriff (PDF)

Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients

AIDS (London), 2007-05, Vol.21 (9), p.1210-1213

2007

Volltextzugriff (PDF)

Uretere Retrocave: Deux Nouvelles Observations à L’hopital Du Point G A Bamako

African journal of urology, 2014-06, Vol.20 (2), p.104-107

2014

Volltextzugriff (PDF)

Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen

AIDS (London), 2011-11, Vol.25 (17), p.2143-2148

2011

Volltextzugriff (PDF)

Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients

AIDS (London), 2000-05, Vol.14 (8), p.987-993

2000

Volltextzugriff (PDF)

Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000

AIDS (London), 2014-05, Vol.28 (8), p.1181-1191

2014

Volltextzugriff (PDF)

Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study

Journal of antimicrobial chemotherapy, 2009-07, Vol.64 (1), p.118-125

2009

Volltextzugriff (PDF)

Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir

Journal of antimicrobial chemotherapy, 2011-08, Vol.66 (8), p.1869-1877

2011

Volltextzugriff (PDF)

Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000

PloS one, 2015-06, Vol.10 (6), p.e0129550-e0129550

2015

Volltextzugriff (PDF)

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients

AIDS (London), 2009-04, Vol.23 (7), p.817-824

2009

Volltextzugriff (PDF)

Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy

AIDS (London), 2008-06, Vol.22 (10), p.1203-1211, Article 1203

2008

Volltextzugriff (PDF)

1 – 25 von 398

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(356)
Mit Volltextzugriff
(328)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(270)
Life Sciences & Biomedicine
(218)
Humans
(194)
Female
(125)
Male
(123)
Biological And Medical Sciences
(106)
Middle Aged
(103)
Adult
(91)
Medical Sciences
(85)
Aged
(57)
Infectious Diseases
(54)
Animals
(53)
Oncology
(42)
Pharmacology. Drug Treatments
(34)
Risk Factors
(33)
Hiv Infections - Drug Therapy
(31)
Immunology
(31)
Fundamental And Applied Biological Sciences. Psychology
(30)
Adolescent
(29)
Human Immunodeficiency Virus
(29)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Choice of initial regimen for antiretroviral-naïve HIV patients: Analysis of motivation

Les urgences andrologiques en milieu urbain au Cameroun: aspects cliniques et thérapeutiques

Social integration of women operated for obstetric urogenital fistula

Prise en charge du priapisme à Dakar

Problématique de la prise en charge des anomalies de la différenciation sexuelle dans le service d’urologie : CHU Point G

Vulval bilharziasis

Localisation vulvaire de la bilharziose

Issues inherent to the management of disorders of sex development in Point G Hospital

Sexuality and fertility of women operated for obstetric urogenital fistulae

Analyse des motivations du choix des antirétroviraux (ARV) prescrits chez des patients infectés par le VIH (PVVIH) naïfs

Gag Mutations Can Impact Virological Response to Dual-Boosted Protease Inhibitor Combinations in Antiretroviral-Naïve HIV-Infected Patients

Intégration sociale des femmes opérées de fistule urogénitale obstétricale

Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial

Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients

Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients

Uretere Retrocave: Deux Nouvelles Observations à L’hopital Du Point G A Bamako

Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen

Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients

Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000

Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study

Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir

Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients

Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy

Suchergebnisse filtern